Search Results - "STAVROPOULOU, Alexandra V"
-
1
Transcriptional Cross Talk between the Forkhead Transcription Factor Forkhead Box O1A and the Progesterone Receptor Coordinates Cell Cycle Regulation and Differentiation in Human Endometrial Stromal Cells
Published in Molecular endocrinology (Baltimore, Md.) (01-10-2007)“…Differentiation of human endometrial stromal cells (HESCs) into decidual cells is associated with induction of the forkhead transcription factor forkhead box…”
Get full text
Journal Article -
2
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases
Published in PloS one (11-03-2013)“…Germline mutations in the BRCA1 and BRCA2 genes contribute to approximately 18% of hereditary ovarian cancers conferring an estimated lifetime risk from 15% to…”
Get full text
Journal Article -
3
Histone Deacetylase Inhibitor Trichostatin A Represses Estrogen Receptor α-Dependent Transcription and Promotes Proteasomal Degradation of Cyclin D1 in Human Breast Carcinoma Cell Lines
Published in Clinical cancer research (01-12-2004)“…Purpose: Estrogen receptor α (ERα)-positive breast cancer cell lines are up to 10 times more sensitive than ERα-negative cell lines to the antiproliferative…”
Get full text
Journal Article -
4
An integrated bacterial system for the discovery of chemical rescuers of disease-associated protein misfolding
Published in Nature biomedical engineering (01-10-2017)“…Protein misfolding and aggregation are common pathological features of several human diseases, including Alzheimer’s disease and type 2 diabetes. Here, we…”
Get full text
Journal Article -
5
Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells
Published in Molecular cancer (20-02-2006)“…Cyclin D1 is an important regulator of G1-S phase cell cycle transition and has been shown to be important for breast cancer development. GSK3beta…”
Get full text
Journal Article -
6
Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells
Published in Molecular cancer (03-10-2006)“…Histone deacetylase inhibitors (HDACIs) have been shown to induce apoptotic and autophagic cell death in vitro and in vivo. The molecular mechanisms that…”
Get full text
Journal Article -
7
The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines
Published in Molecular cancer (17-02-2006)“…The cyclin D1 proto-oncogene is an important regulator of G1 to S-phase transition and an important cofactor for several transcription factors in numerous cell…”
Get full text
Journal Article -
8
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Published in Breast cancer research and treatment (01-07-2012)“…In spite the close association of the triple-negative breast cancer immunophenotype with hereditary breast cancers and the BRCA1 pathway, there is a lack of…”
Get full text
Journal Article -
9
Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
Published in PloS one (17-04-2013)“…Investing in knowledge society through the European Social Fund. (2013) Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer…”
Get full text
Journal Article -
10
In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3' -deoxy-3'-[18F]fluorothymidine positron emission tomography
Published in Cancer research (Chicago, Ill.) (01-08-2006)“…Histone deacetylase inhibitors (HDACI) are emerging as growth inhibitory compounds that modulate gene expression and inhibit tumor cell proliferation. We…”
Get full text
Journal Article -
11
Publisher Correction: An integrated bacterial system for the discovery of chemical rescuers of disease-associated protein misfolding
Published in Nature biomedical engineering (2018)“…In the version of this Article originally published, in Fig. 1c–e, on the x axes, the lines labelled ‘Aβ 42 ’ and ‘Aβ 42 (F19S;L34P)’ grouped the data…”
Get full text
Journal Article -
12
novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells
Published in The FEBS journal (01-08-2009)“…Screening a compound library of compound 48/80 analogues, we identified 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate (E1) as a novel…”
Get full text
Journal Article -
13
FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
Published in Oncogene (20-05-2010)“…In this study, we investigated the regulation of FOXM1 expression by estrogen receptor α (ERα) and its role in hormonal therapy and endocrine resistance. FOXM1…”
Get full text
Journal Article -
14
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Published in Breast cancer research and treatment (01-07-2012)“…In spite the close association of the triple-negative breast cancer immunophenotype with hereditary breast cancers and the BRCA1 pathway, there is a lack of…”
Get full text
Journal Article -
15
-
16
Correction: Prevalence of Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
Published in PloS one (01-01-2013)Get full text
Journal Article